These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4446534)

  • 1. [Secretin as a possible therapeutic agent in ulcer disease].
    Geller LI; Glinskaia TP; Kozlova ZP
    Vrach Delo; 1974 Dec; (12):55-8. PubMed ID: 4446534
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of secretin and cholecystokinin on gastric emptying and gastric secretion in man.
    Chey WY; Hitanant S; Hendricks J; Lorber SH
    Gastroenterology; 1970 Jun; 58(6):820-7. PubMed ID: 5423893
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of subcutaneous and intravenous secretin in man.
    Isenberg JI; Grossman MI
    Gastroenterology; 1969 Jan; 56(1):88-91. PubMed ID: 5765434
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of duodenal ulcer with a long-acting synthetic secretin: a pilot trial.
    Demling L; Domschke W; Domschke S; Belohlavek D; Baenkler HW; Frühmorgen P; Lingenberg G; Wünsch E; Jaeger E
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):310-3. PubMed ID: 53980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal effects of long-term treatment of duodenal ulcer with depot secretin: clinical, secretory, ultra-structural, and enzymological aspects.
    Demling L; Domschke W; Riemann JF; Domschke S; Ruppin H; Junge O; Wünsch E
    Scand J Gastroenterol Suppl; 1976; 42():136-45. PubMed ID: 796967
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatic dose-response curves to intravenous secretin in man.
    Konturek SJ
    Gastroenterology; 1970 Jun; 58(6):828-32. PubMed ID: 5463729
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical effects of "Secrepan", a secretin preparation, on duodenal ulcer].
    Ishikawa M; Kataoka S; Ueno T; Takahashi T; Goto T
    Horumon To Rinsho; 1979 Jan; 27(1):115-20. PubMed ID: 428120
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of duodenal ulcer with synthetic depot secretin - a double-blind study].
    Scholten T; Fritsch WP; Hagenmüller F; Classen M; Knop P; Hausamen TU; Lingenberg G; Portocarrero G; Safrany L; Seifert E; Zeus U; Stadelmann O
    Z Gastroenterol; 1983 May; 21(5):212-9. PubMed ID: 6349151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with synthetic secretin in the treatment of duodenal ulcer.
    Henn RM; Selcon S; Sturdevant RA; Isenberg JI; Grossman MI
    Am J Dig Dis; 1976 Nov; 21(11):921-5. PubMed ID: 790943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A trial of exogenous secretin in the treatment of duodenal ulcer pain.
    Höj L; Holst JJ; Rune SJ
    Scand J Gastroenterol; 1973; 8(3):279-81. PubMed ID: 4724928
    [No Abstract]   [Full Text] [Related]  

  • 11. The pancreatic exocrine secretion in duodenal ulcer patients before and after selective proximal vagotomy of the stomach.
    Berstad A; Roland M; Petersen H; Liaväg I
    Scand J Gastroenterol; 1974; 9(5):431-6. PubMed ID: 4854985
    [No Abstract]   [Full Text] [Related]  

  • 12. The gastric acidity and the incidence of chronic atrophic gastritis in normal subjects and in patients with duodenal ulcer and non-ulcer dyspepsia.
    Satija VK; Joseph S; Cowan B
    J Assoc Physicians India; 1968 Jun; 16(6):335-6. PubMed ID: 5716433
    [No Abstract]   [Full Text] [Related]  

  • 13. The gastric acid secretory response to submaximal and maximal continuous intravenous histamine stimulation in patients with duodenal ulcer.
    Dahlgren S; Nordgren B
    Scand J Gastroenterol; 1970; 5(6):513-7. PubMed ID: 5460414
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acidity of gastric juice and activity of pepsin before and after vagotomy].
    Karski J; Papliński Z
    Pol Przegl Chir; 1969 Dec; 41(12):1683-6. PubMed ID: 4906455
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hydrochloric acid secretion in gastric juice after histamine stimulation and 24-hour urinary excretion of 5-hydroxyindoleacetic acid in patients with gastric and duodenal ulcer treated with spasmophen].
    Pokora J; Czarnecki J
    Pol Tyg Lek; 1968 Dec; 23(50):1925-7. PubMed ID: 5715560
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes of some constituents of gastric secretion in patients with duodenal ulcer, due to the action of beta-blocking agents].
    Baciu Z; Duţu D; Ghircoiaşu T; Pop N; Gabor S; Păsculescu G; Cseke G; Zirbo M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(4):329-34. PubMed ID: 6131515
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acid secretion in duodenal ulcer and pseudo-ulcer syndrome].
    Nielsen VG; Jorgensen B
    Ugeskr Laeger; 1971 May; 133(21):1025-7. PubMed ID: 5088314
    [No Abstract]   [Full Text] [Related]  

  • 18. Stimulation of pancreatic secretion in man by secretin snuff.
    B'Hend P; Hadorn B; Haldemann B; Kleeb M; Lüthi H
    Lancet; 1973 Mar; 1(7802):509-10. PubMed ID: 4119948
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of xylite on gastric secretion and on the exocrinic function of the pancreasin peptic ulcer of the duodenum].
    Vaĭnshteĭn SG; Pivikova MI; Maksudova DKh
    Vopr Pitan; 1973; 32(1):14-7. PubMed ID: 4780609
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quantitative gastric juice analyses in surgical patients].
    Templin R; Wolf E; Rosenbaum KD; Petermann J
    Zentralbl Chir; 1972 May; 97(21):673-7. PubMed ID: 5051579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.